Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 1
1995 1
1999 1
2001 3
2003 2
2004 3
2005 3
2006 2
2009 1
2010 1
2011 1
2012 3
2013 4
2014 6
2015 7
2016 3
2017 6
2018 5
2019 5
2020 10
2021 13
2022 10
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Attributes and predictors of long COVID.
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Sudre CH, et al. Among authors: molteni e. Nat Med. 2021 Apr;27(4):626-631. doi: 10.1038/s41591-021-01292-y. Epub 2021 Mar 10. Nat Med. 2021. PMID: 33692530 Free PMC article.
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, Molteni E, Canas L, Österdahl MF, Modat M, Sudre CH, Fox B, Hammers A, Wolf J, Capdevila J, Chan AT, David SP, Steves CJ, Ourselin S, Spector TD. Menni C, et al. Among authors: molteni e. Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7. Lancet. 2022. PMID: 35397851 Free PMC article.
Eligible participants were aged 16-99 years, based in the UK, with a body-mass index between 15 and 55 kg/m(2), had received at least two doses of any SARS-CoV-2 vaccine, were symptomatic, and logged a positive symptomatic PCR or lateral flow result for SARS-CoV-2 during t …
Eligible participants were aged 16-99 years, based in the UK, with a body-mass index between 15 and 55 kg/m(2), had received at least …
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, Hu C, Selvachandran S, Antonelli M, Murray B, Canas LS, Molteni E, Graham MS, Modat M, Joshi AD, Mangino M, Hammers A, Goodman AL, Chan AT, Wolf J, Steves CJ, Valdes AM, Ourselin S, Spector TD. Menni C, et al. Among authors: molteni e. Lancet Infect Dis. 2021 Jul;21(7):939-949. doi: 10.1016/S1473-3099(21)00224-3. Epub 2021 Apr 27. Lancet Infect Dis. 2021. PMID: 33930320 Free PMC article.
All analyses were adjusted by age (55 years vs >55 years), sex, health-care worker status (binary variable), obesity (BMI <30 kg/m(2)vs 30 kg/m(2)), and comorbidities (binary variable, with or without comorbidities). ...
All analyses were adjusted by age (55 years vs >55 years), sex, health-care worker status (binary variable), obesity (BMI <30 kg/m …
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, Canas LS, Graham MS, Klaser K, Modat M, Murray B, Kerfoot E, Chen L, Deng J, Österdahl MF, Cheetham NJ, Drew DA, Nguyen LH, Pujol JC, Hu C, Selvachandran S, Polidori L, May A, Wolf J, Chan AT, Hammers A, Duncan EL, Spector TD, Ourselin S, Steves CJ. Antonelli M, et al. Among authors: molteni e. Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1. Lancet Infect Dis. 2022. PMID: 34480857 Free PMC article.
In the risk factor analysis, frailty was associated with post-vaccination infection in older adults (60 years) after their first vaccine dose (odds ratio [OR] 1.93, 95% CI 1.50-2.48; p<0.0001), and individuals living in highly deprived areas had increased odds of post-vaccinat …
In the risk factor analysis, frailty was associated with post-vaccination infection in older adults (60 years) after their first vaccine dos …
Scoping Review on the Diagnosis, Prognosis, and Treatment of Pediatric Disorders of Consciousness.
Molteni E, Canas LDS, Briand MM, Estraneo A, Font CC, Formisano R, Fufaeva E, Gosseries O, Howarth RA, Lanteri P, Licandro GI, Magee WL, Veeramuthu V, Wilson P, Yamaki T, Slomine BS; as the Special Interest Group on DoC of the International Brain Injury Association (IBIA-DoC SIG). Molteni E, et al. Neurology. 2023 Aug 8;101(6):e581-e593. doi: 10.1212/WNL.0000000000207473. Epub 2023 Jun 12. Neurology. 2023. PMID: 37308301 Free PMC article. Review.
Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.
Buroni S, Pasca MR, de Jesus Lopes Ribeiro AL, Degiacomi G, Molteni E, Riccardi G. Buroni S, et al. Among authors: molteni e. Appl Microbiol Biotechnol. 2012 May;94(4):907-16. doi: 10.1007/s00253-012-4013-4. Epub 2012 Apr 18. Appl Microbiol Biotechnol. 2012. Retraction in: Appl Microbiol Biotechnol. 2012 Sep;95(5):1369. doi: 10.1007/s00253-012-4217-7. PMID: 22526781 Retracted. Review.
A few new tuberculosis vaccines are now in various phases of clinical trials. The emergence of multidrug-resistant strains of M. tuberculosis gave the impulse to discover new effective antitubercular drugs, a few of which are in clinical development. ...
A few new tuberculosis vaccines are now in various phases of clinical trials. The emergence of multidrug-resistant strains of M. tube …
Celiac disease in autism spectrum disorder: data from an Italian child cohort.
Zambrano S, Parma B, Morabito V, Borini S, Romaniello R, Molteni M, Mani E, Selicorni A. Zambrano S, et al. Among authors: molteni m. Ital J Pediatr. 2023 Jul 3;49(1):79. doi: 10.1186/s13052-023-01484-x. Ital J Pediatr. 2023. PMID: 37400878 Free PMC article.
A serological celiac disease screening was performed and data were available for 196 patients; male (M):female (F) ratio = 4.4:1; median age = 3.6 years; age range = 1.6-12.8 years. ...
A serological celiac disease screening was performed and data were available for 196 patients; male (M):female (F) ratio = 4.4:1; med …
Mycobacterium lentiflavum infection in immunocompetent patient.
Molteni C, Gazzola L, Cesari M, Lombardi A, Salerno F, Tortoli E, Codecasa L, Penati V, Franzetti F, Gori A. Molteni C, et al. Emerg Infect Dis. 2005 Jan;11(1):119-22. doi: 10.3201/eid1101.040523. Emerg Infect Dis. 2005. PMID: 15705334 Free PMC article. Review.
Our observation confirms clinical, diagnostic, and treatment difficulties in the management of M. lentiflavum infection....
Our observation confirms clinical, diagnostic, and treatment difficulties in the management of M. lentiflavum infection....
90 results